METTL3 is up-regulated in HCC and inhibits the suppressor of cytokine signaling 2 (SOCS2) expression through an m6 A-YTHDF2-dependent mechanism, thus stimulating HCC progression [93, 106]. The gene discussed is METTL3; the disease is hepatocellular carcinoma.